Could dietary seaweed reverse the metabolic syndrome?

Asia Pacific Journal of Clinical Nutrition

Volumn 18, Issue 2, 2009, Pages 145-154

  Teas, Jane ^a   Baldeón, Manuel E ^b   Chiriboga, David E ^c   Davis, Jennifer R ^a   Sarriés, Alejandro J ^d   Braverman, Lewis E ^e  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSIDAD SAN FRANCISCO DE QUITO   (Ecuador)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d Centro Cardiologico Trelew   (Argentina)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Hypertension; Iodine; Metabolic syndrome; Seaweed; Waist circumference

Indexed keywords

UNDARIA; UNDARIA PINNATIFIDA;

IODINE; LIPID; PLACEBO;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEAWEED; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; BODY WEIGHT; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IODINE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLACEBOS; SEAWEED; WAIST CIRCUMFERENCE;

EID: 70349577138     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-27.
2. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr. 1999;53:83-7.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:3:356-9.
4. Barnard RJ, Aronson WJ. Preclinical models relevant to diet, exercise, and cancer risk. Recent Results Cancer Res. 2005; 166:47-61.
5. Guastamacchia E, Resta F, Triggiani V, Liso A, Licchelli B, Ghiyasaldin S, Sabbà C, Tafaro E. Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors. Curr Drug Targets Immune Endocr Metabol Disord. 2004;4:59-66.
6. Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH. Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev. 2002;3:303-08.
7. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, Group DS. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066-76.
8. Prospective Collaboration Study. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
9. Jung H, Hyun S, Kim H, Choi J. Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Science. 2006;72:1292-9.
10. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health. 2005;47:126-35.
11. Yamori Y, Miura A, Taira K. Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. Asia Pac J Clin Nutr. 2001;10: 144-5.
12. Shimazu T, Kuriyama S, Hozawa A, Ohmori K, Sato Y, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol. 2007;36:600-9.
13. Kibayashi E, Yokogoshi H, Mizue H, Miura K, Yoshita K, Nakagawa H, Naruse Y, Sokejima S, Kagamimori S. Daily dietary taurine intake in Japan. Adv Exp Med Biol. 2000; 483:137-42.
14. Funayama S, Hikino H. Hypotensive principle of Laminaria and allied seaweeds. Planta Med. 1981;41:29-33.
15. Girard JP, Marion C, Liutkus M, Boucard M, Rechencq E, Vidal JP, Rossi JC. Hypotensive constituents of marine algae; 1. Pharmacological studies of laminine. Planta Med. 1988;54:193-6.
16. Arasaki S, Arasaki T. Vegetables from the Sea. Tokyo: Japan Publications Inc; 1983.
17. Sato M, Oba T, Yamaguchi T, Nakano T, Kahara T, Funayama K, Kobayashi A, Nakano T. Antihypertensive effects of hydrolysates of Wakame (Undaria pinnatifida) and their angiotensin-I-converting enzyme inhibitory activity. Ann Nutr Metab. 2002;46:259-67.
18. Suetsuna K, Maekawa K, Chen J. Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J Nutr Biochem. 2004; 15:267-72.
19. Suetsuna K, Nakano T. Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem. 2000;11:450-4.
20. Suetsuna K. Novel Undaria pinnatifida peptide, L-tyrosyl-L-proline, as hypotensive agent, Japanese patent 2007 182415 A 20070719; 2007.
21. Chaki T, Amano H, Kajimoto O, Baba T. Dose dependency of sodium alginate oligosaccharides in a randomized double-blind placebo-controlled clinical study in subjects with high normal blood pressure and mild hypertension Yakuri to chiryo. Basic Pharmacology & Therapeutics. 2006;34:1267-77.
22. Paxman J, Richardson J, Dettmarc P, Corfea B. Alginate reduces the increased uptake of cholesterol and glucose in overweight male subjects: a pilot study. Nutr Res. 2008;28: 501-5.
23. Townsend R, McFadden C, Ford V, Cadee J. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens. 2004;17:1056-8.
24. Nagayama I, Notsu A, Noda H, Otsuka Y. Relationship between dietary fiber intake and food intake patterns of the general population, evaluated by a regional nutrition survey. Japanese Journal of Public Health. 1998;45:634-44.
25. Ono A, Shibaoka M, Yano J, Asai Y, Fujita T. Eating habits and intensity of medication in elderly hypertensive outpatients. Hypertens Res. 2000;23:195-200.
26. Hata Y, Nakajima K, Uchida J, Hidaka H, Nakano T. Clinical effects of brown seaweed, Undaria pinnatifida (wakame), on blood pressure in hypertensive subjects. J Clin Biochem Nutr. 2001;30:43-53.
27. Krotkiewski M, Aurell M, Holm G, Grimby G, Szczepanik J. Effects of sodium-potassium ion-exchanging seaweed preparation in mild hypertension. Am J Hypertens. 1991;4: 483-8.
28. Maeda H, Hosokawa M, Sahima T, Funayama K, Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissue. Biochem Biophys Res Commun. 2005;332: 392-7.
29. Maeda H, Tsukui T, Sashima T, Hosokawa M, Miyashita K. Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient. Asia Pac J Clin Nutr. 2008;17(S1):196-9.
30. Chiriboga D, Fornasini M. Trends in coronary heart disease and diabetes in Ecuador 1993 - 2003: Secondary Data Analyses from INEC: Instituto Nacional de Estadísticas y Censos. Worcester and Quito: University of Massachusetts Medical School, Massachusetts; Universidad San Francisco de Quito, Ecuador; 2005.
31. Zevallos J, Ockene I, Chiriboga D, Callay S, Baca M. The impact of urbanization on cardiovascular risk factors in an indigenous population of the highlands of Ecuador. Clinica Pichincha, Quito, Ecuador. Worcester: Preventive Cardiology University of Massachusetts Medical School; 1991.
32. Castro Burbano J, Fornasini M, Acosta M. Prevalence of and risk factors for overweight among school girls 12 to 19 years old in a semi-urban region of Ecuador. Rev Panam Salud Publica. 2003;13:277-84.
33. Braguinsky J. Obesity prevalence in Latin America. An Sist Sanit Navar. 2002;25 (S1):109-15.
34. Ockene J, Chiriboga D, Zevallos J. Smoking in Ecuador: prevalence, knowledge, and attitudes. Tob Control. 1996;5: 121-6
35. Padgett D, Selwyn B, Kelder S. Ecuadorian adolescents and cigarette smoking: A cross-sectional survey. Rev Panam Salud Publica. Aug 1998;4:87-93.
36. Sánchez P, Lisanti N. The prevalence of and attitudes toward smoking among physicians in Azuay, Ecuador. Rev Panam Salud Publica. 2003;14:25-30.
37. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
38. Maruyama H, Tamauchi H, Hashimoto M, Nakano T. Antitumor activity and immune response of Mekabu fucoidan extracted from sporophyll of Undaria pinnatifida. In Vivo. 2003;17:245-9.
39. PAHO PAHI. Working meeting on blood pressure measurement: suggestions for measuring blood pressure to use in populations surveys. Rev Panam Salud Publica. 2003;14: 300-2.
40. Lean M, Han T, Morrison C. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311:158-61.
41. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
42. Teran E, Escudero C, Vivero S. Physiological changes in platelet aggregation and nitric oxide levels during menstrual cycle in healthy women. Nitric Oxide. 2002;7:217-20.
43. PAHO. Advancing the people's health Annual Report of the Director-2000; 2000:46.
44. Teas J, Braverman L, Kurzer M, Pino S, Hurley T, Hebert J. Seaweed and soy: Companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food. 2007;10:90-100.
45. Teas J, Pino S, Critchley A, Braverman LE. Variability of iodine content in common commercially available edible seaweeds. Thyroid. 2004;14:836-41.
46. Ministry of Health of Japan. The National Nutrition Survey in Japan, 2002: Dai-ichi shuppan, Tokyo, Japan; 2004. [in Japanese]
47. Shin A, Lim S-Y, Sung J, Shin H-R, Kim J. Dietary intake, eating habits, and metabolic syndrome in Korean men. J Am Diet Assoc. 2009;109:633-40.
48. Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study. Hypertens Res. 2008;31:2027-35.
49. Kim M-J, Chang U-J, Lee J-S. Inhibitory effects of fucoidan in 3T3-L1 adipocyte differentiation. Mar Biotechnol (NY) Dec 10 2008 [Epub ahead of print].
50. Campbell S, Bite J, Burridge T. Seasonal patterns in the photosynthetic capacity, tissue pigment and nutrient content of different developmental stages of Undaria pinnatifida (Phaeophyta: Laminariales) in Port Phillip Bay, South-Eastern Australia. Botanica Marina 1999;42:231-41.
51. Carnachan S, Falshaw R. Analysis of three samples of sporophyll of the brown seaweed, Undaria pinnatifida and three samples of processed wakame (prepared from leaf of the brown seaweed, Undaria pinnatifida). Industrial Research Ltd; 2008.
52. Jones D. Dietary sodium and blood pressure. Hypertension. 2004;43:932-5.
53. Ikeda K, Kitamura A, Machida H, Watanabe M, Negishi H, Hiraoka J, Nakano T. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2003;30:44-8.
54. Chaki T, Kajimoto N, Ogawa H, Baba TW, Hiura N. Metabolism and calcium antagonism of sodium alginate oligosaccharides. Biosci Biotechnol Biochem. 2007;71:1819-25.
55. Apoya M, Ogawa H, Nanba N. Alginate content of farmed Undaria pinnatifida (Harvey) suringar from the three bays of Iwate, Japan during harvest period. Botanica Marina. 2002;45:445-52.
56. Skriptsova A, Khomenko V, Isakov V. Seasonal changes in growth rate, morphology and alginate content in Undaria pinnatifida at the northern limit in the Sea of Japan (Russia). J Appl Phycol. 2004;16:17-21.